02 Jul What Patients Should Know Before Choosing an Alcohol Rehab Program
Mental Health Notice: If you are experiencing significant stress, anxiety, or low mood, please speak with a qualified healthcare professional. You can contact the 988 Suicide & Crisis Lifeline by calling or texting 988 (24/7), or the Crisis Text Line by texting HOME to 741741. In a life-threatening situation, call 911.
If you or someone you know is struggling with addiction or in crisis: Call or text the SAMHSA National Helpline at 1-800-662-4357 (free, confidential, 24/7) or call/text the 988 Suicide and Crisis Lifeline at 988. In an emergency, call 911.
Choosing to seek treatment for alcohol use disorder is a significant and often life-changing decision. Once an individual recognizes the need for help, the next challenge is determining which treatment program is the right fit. With many different types of rehabilitation programs available, understanding what to look for can help patients and families make more informed decisions about care.
Recovery is not a one-size-fits-all process. Every person's experiences, health history, and recovery goals are unique, making individualized treatment one of the most important factors when selecting a rehabilitation program.
Dr. Edward Liu[/caption]
MedicalResearch.com Interview with:
Edward Liu, MD
Geisinger College of Health Sciences
Scranton, PA 18509
Medicalresearch.com: What is the background for this study?
Response: Prescription drugs have high levels of uniformity that plant-based products cannot achieve. Given the liberalization of state-laws regarding medical marijuana1 over the past three-decades and increasing evidence of evidence of cannabis for conditions like chronic pain,2 we were interested in the use of the prescription formulation of delta(Δ)9-tetrahydrocannabinol (THC). A prior pharmacoepidemiology report found that prescription THC (dronabinol) to Medicaid patients decreased from 2016 to 2020. There were also pronounced state-level disparities in prescribing with a 130-fold difference when correcting for population between the highest and lowest states.
There was no research on this topic among Medicare patients. To address this gap, we obtained prescription numbers nationally and at a state level from 2014 to 2019 for Medicare Part D patients.
Source: IMAGE[/caption]